HeraNova develops diagnostic tests for women's health conditions, including a non-invasive miRNA panel-based test for the detection and confirmation of endometriosis.
investor of
Metrics
marketPRIVATE
msh_idCOM:HERANOVA
localeus
websitehttps://heranova.com/
source_ref7bb5d1a3-cddc-4ad8-8d32-dbdb17d77569
products_or_servicesDiagnostic tests for women's health conditions, including HerResolve™, a non-invasive miRNA panel-based test for endometriosis detection and confirmation
United States